June 2026 FDA Recall Minocycline Hydrochloride by Ascend Laboratories, Llc
D-0597-2026 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Ascend Laboratories, Llc on June 1, 2026 for the product Minocycline Hydrochloride. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0597-2026

Reason for Recall
Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
Initiated
06-01-2026
Reported
06-17-2026
Quantity
360 30-count bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Ascend Laboratories, LLC
Nationwide in the USA
Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-644-30

Batch or Lot Expiration Information

Lot# 25141635, Exp 4/30/2028